Overview
- Patients with six or more gabapentin prescriptions had a 29% higher risk of dementia and an 85% higher risk of mild cognitive impairment within ten years compared to those with fewer prescriptions.
- Individuals who filled 12 or more prescriptions showed a 40% increased dementia risk and a 65% increased MCI risk relative to patients with three to eleven prescriptions.
- Age-stratified analysis found adults aged 35–49 experienced more than double the dementia risk and over triple the MCI risk, while no elevated risk emerged for those aged 18–34.
- Researchers examined anonymized records of approximately 26,400 gabapentin users and matched controls from the TriNetX network covering 68 U.S. healthcare organizations between 2004 and 2024.
- Study authors cautioned that the retrospective, observational design precludes causal inference and urged close cognitive monitoring for patients on long-term gabapentin therapy.